Price To Earnings Ratio 11.22 | Sector PE 37.36 |
PB Ratio 1.38 | Sector PB 7.54 |
EPS 10.46 | Dividend Yield 2.87 |
Today's Volume 332.327 K | 5 Day Avg. Volume 597.510 K |
PEG Ratio 0.27 | Market Cap. ₹ 3,080.00 Cr. |
Alembic Limited is an Indian company that develops, manufactures and markets pharmaceutical products such as dosage forms and active ingredients. The company operates through one segment, Pharmaceuticals. The Pharmaceutical segment manufactures and markets fermentation and chemical-based active ingredients (API). The company also conducts R&D in Vadodara. The company manufactures/provides three main products/services: Azithromycin, Venlafaxine and Telmisartan.